These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37016935)

  • 21. Psychosocial correlates of apparent treatment-resistant hypertension in the Jackson Heart Study.
    Shallcross AJ; Butler M; Tanner RM; Bress AP; Muntner P; Shimbo D; Ogedegbe G; Sims M; Spruill TM
    J Hum Hypertens; 2017 Jul; 31(7):474-478. PubMed ID: 28124682
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Single Agent Antihypertensive Therapy and Orthostatic Blood Pressure Behaviour in Older Adults Using Beat-to-Beat Measurements: The Irish Longitudinal Study on Ageing.
    Canney M; O'Connell MD; Murphy CM; O'Leary N; Little MA; O'Seaghdha CM; Kenny RA
    PLoS One; 2016; 11(1):e0146156. PubMed ID: 26730962
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic kidney disease and incident apparent treatment-resistant hypertension among blacks: Data from the Jackson Heart Study.
    Tanner RM; Shimbo D; Irvin MR; Spruill TM; Bromfield SG; Seals SR; Young BA; Muntner P
    J Clin Hypertens (Greenwich); 2017 Nov; 19(11):1117-1124. PubMed ID: 28921875
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apparent treatment-resistant hypertension: characteristics and prevalence in a real-world environment of an integrated health system.
    An J; Sim JJ; Calhoun DA; Liu R; Wei R; Zhou H; Luong T; Reynolds K
    J Hypertens; 2020 Aug; 38(8):1603-1611. PubMed ID: 32251197
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of uric acid-lowering therapy on blood pressure: systematic review and meta-analysis.
    Qu LH; Jiang H; Chen JH
    Ann Med; 2017 Mar; 49(2):142-156. PubMed ID: 27689859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dose-response association of uncontrolled blood pressure and cardiovascular disease risk factors with hyperuricemia and gout.
    Juraschek SP; Kovell LC; Miller ER; Gelber AC
    PLoS One; 2013; 8(2):e56546. PubMed ID: 23460805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urban-rural differences in hypertension prevalence, blood pressure control, and systolic blood pressure levels.
    Heindl B; Howard G; Clarkson S; Kamin Mukaz D; Lackland D; Muntner P; Jackson EA
    J Hum Hypertens; 2023 Dec; 37(12):1112-1118. PubMed ID: 37407675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. National patterns in intensity and frequency of outpatient care for apparent treatment-resistant hypertension.
    Vemulapalli S; Deng L; Patel MR; Kilgore ML; Jones WS; Curtis LH; Irvin MR; Svetkey LP; Shimbo D; Calhoun DA; Muntner P
    Am Heart J; 2017 Apr; 186():29-39. PubMed ID: 28454830
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Withdrawal of antihypertensive drugs in older people.
    Reeve E; Jordan V; Thompson W; Sawan M; Todd A; Gammie TM; Hopper I; Hilmer SN; Gnjidic D
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD012572. PubMed ID: 32519776
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
    Evid Based Child Health; 2014 Sep; 9(3):498-580. PubMed ID: 25236305
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The association of nocturnal hypertension and nondipping blood pressure with treatment-resistant hypertension: The Jackson Heart Study.
    Irvin MR; Booth JN; Sims M; Bress AP; Abdalla M; Shimbo D; Calhoun DA; Muntner P
    J Clin Hypertens (Greenwich); 2018 Mar; 20(3):438-446. PubMed ID: 29436105
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incident hyperuricemia in relation to antihypertensive therapy with the irbesartan/hydrochlorothiazide combination.
    Zhang D; Huang QF; Li Y; Wang JG
    Blood Press Monit; 2021 Dec; 26(6):413-418. PubMed ID: 34128490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Healthy lifestyle factors and risk of cardiovascular events and mortality in treatment-resistant hypertension: the Reasons for Geographic and Racial Differences in Stroke study.
    Diaz KM; Booth JN; Calhoun DA; Irvin MR; Howard G; Safford MM; Muntner P; Shimbo D
    Hypertension; 2014 Sep; 64(3):465-71. PubMed ID: 24914189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of blood pressure lowering on outcome incidence in hypertension: 2. Effects at different baseline and achieved blood pressure levels--overview and meta-analyses of randomized trials.
    Thomopoulos C; Parati G; Zanchetti A
    J Hypertens; 2014 Dec; 32(12):2296-304. PubMed ID: 25259547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regular alcohol drinking is a determinant of masked morning hypertension detected by home blood pressure monitoring in medicated hypertensive patients with well-controlled clinic blood pressure: the Jichi Morning Hypertension Research (J-MORE) study.
    Ishikawa J; Kario K; Eguchi K; Morinari M; Hoshide S; Ishikawa S; Shimada K;
    Hypertens Res; 2006 Sep; 29(9):679-86. PubMed ID: 17249523
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genome-Wide Association Study of Apparent Treatment-Resistant Hypertension in the CHARGE Consortium: The CHARGE Pharmacogenetics Working Group.
    Irvin MR; Sitlani CM; Floyd JS; Psaty BM; Bis JC; Wiggins KL; Whitsel EA; Sturmer T; Stewart J; Raffield L; Sun F; Liu CT; Xu H; Cupples AL; Tanner RM; Rossing P; Smith A; Zilhão NR; Launer LJ; Noordam R; Rotter JI; Yao J; Li X; Guo X; Limdi N; Sundaresan A; Lange L; Correa A; Stott DJ; Ford I; Jukema JW; Gudnason V; Mook-Kanamori DO; Trompet S; Palmas W; Warren HR; Hellwege JN; Giri A; O'donnell C; Hung AM; Edwards TL; Ahluwalia TS; Arnett DK; Avery CL
    Am J Hypertens; 2019 Nov; 32(12):1146-1153. PubMed ID: 31545351
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors associated with antihypertensive medication use and blood pressure control in a rural area in Bangladesh: baseline data from a cluster randomised control trial.
    Amirul Islam FM; Lambert EA; Islam SMS; Islam MA; Maddison R; Thompson B; Lambert GW
    BMC Public Health; 2021 Dec; 21(1):2316. PubMed ID: 34949160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and characteristics of apparent treatment-resistant hypertension in older people in China: a cross-sectional study.
    Wu C; Wang Y; Zhang W; Li X; Wang L; Hui R
    Clin Exp Hypertens; 2019; 41(8):753-758. PubMed ID: 30512984
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cochrane in context: pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh RS
    Evid Based Child Health; 2014 Sep; 9(3):581-3. PubMed ID: 25236306
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Asymptomatic hyperuricemia is a strong risk factor for resistant hypertension in elderly subjects from general population.
    Mazza A; Lenti S; Schiavon L; Monte AD; Townsend DM; Ramazzina E; Rubello D; Casiglia E
    Biomed Pharmacother; 2017 Feb; 86():590-594. PubMed ID: 28027534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.